Skip to search formSkip to main contentSkip to account menu

Triptans

Derivatives of TRYPTAMINES that are SEROTONIN RECEPTOR AGONISTS acting at 5-HT1 RECEPTORS. Some are used to treat MIGRAINE DISORDERS.
National Institutes of Health

Related topics

Related topics

3 relations

Broader (2)

Serotonin 5-HT1 Receptor AgonistsTryptamines

Narrower (1)

Sumatriptan

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
A shot at migraine.
Millions dread the onset of migraine headaches, which strike roughly 12% of the world9s population at least once per year… 
Review
2008
Review
2008
Early Treatment in Migraine: How Strong is the Current Evidence?
Over the last 10 years, triptans (serotonin 5-HT1B/1D receptor agonists) have proved to be efficacious in treating migraine pain… 
2008
2008
Triptans and Serotonin Syndrome
Dear Sir I read the article, ‘Serotonin syndrome and rhabdomyolysis induced by concomitant use of triptans, fluoxetine and… 
Review
2006
Review
2006
Topiramate Prophylaxis and Response to Triptan Treatment for Acute Migraine
Objective.—To evaluate the effect of topiramate migraine prophylaxis on subject responsiveness to triptans used for acute… 
Review
2006
Review
2006
Utilisation clinique des triptans dans la prise en charge de la migraine
The discovery of the triptans (selective serotonin agonists 5HT1B/1D), with 7 compounds (almotriptan, eletriptan, frovatriptan… 
2005
2005
Naratriptan in the Preventive Treatment of Refractory Transformed Migraine: A Prospective Pilot Study
Objective.—To assess the efficacy, safety, and tolerability of daily naratriptan in the preventive treatment of transformed… 
2005
2005
Triptans for Migraine Therapy: A Comparison Based on Number Needed to Treat and Doses Needed to Treat
OBJECTIVES: Managed care and other decision makers need sound comparative information to support the formulary selection process… 
Review
2005
Review
2005
Patient satisfaction with migraine management by family physicians.
Over 70% of the estimated 5 million office visits per year for migraine headache are to family physicians. Both the number of… 
Review
2004
Review
2004
Views and Perspectives Consensus Statement: Cardiovascular Safety Profile of Triptans (5-HT 1B/1D Agonists) in the Acute Treatment of Migraine
Background.—Health care providers frequently cite concerns about cardiovascular safety of the triptans as a barrier to their use… 
Review
2001
Review
2001
Acute treatment of migraine and the role of triptans
The use of triptans has improved the ability to treat migraine successfully compared with older treatments. Speed of relief… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)